A very recent study has reported that the pleiotropic roles of low ATP6V1A levels in AD pathogenesis are mediated via the synaptic vesicle cycle, phagosome, and oxidative phosphorylation (Zhou et al., 2021), which is consistent with results of this study. Here, ATP6V1A is linked to Alzheimer disease.